152 related articles for article (PubMed ID: 9542473)
1. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
[TBL] [Abstract][Full Text] [Related]
2. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
3. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
O'Shea D; Davis SN; Kim RB; Wilkinson GR
Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
[TBL] [Abstract][Full Text] [Related]
4. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
Draper AJ; Madan A; Latham J; Parkinson A
Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
6. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
[TBL] [Abstract][Full Text] [Related]
7. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping of cytochrome P450 2E1 in vitro and in vivo.
Ernstgård L; Johanson G; Karlsson AS; Warholm M
Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020
[TBL] [Abstract][Full Text] [Related]
9. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects.
Bedada SK; Neerati P
Eur J Clin Pharmacol; 2018 Jan; 74(1):91-97. PubMed ID: 28983678
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
[TBL] [Abstract][Full Text] [Related]
11. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
[TBL] [Abstract][Full Text] [Related]
12. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
Mizuno D; Tanaka E; Tanno K; Misawa S
Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
[TBL] [Abstract][Full Text] [Related]
13. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
[TBL] [Abstract][Full Text] [Related]
14. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
Park JY; Kim KA; Park PW; Ha JM
J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
[TBL] [Abstract][Full Text] [Related]
16. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Baek HW; Bae SK; Lee MG; Sohn YT
J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
O'Shea D; Kim RB; Wilkinson GR
Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
[TBL] [Abstract][Full Text] [Related]
19. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
Ernstgård L; Warholm M; Johanson G
Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
[TBL] [Abstract][Full Text] [Related]
20. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
